Why the study?
Previous studies did not clearly show superior clinical efficacy of contact force-sensing catheters compared with non-contact force catheters for pulmonary vein isolation in atrial fibrillation.
Does contact force-sensing catheter ablation reduce atrial fibrillation or atrial tachycardia recurrence compared to non-contact force ablation in patients with atrial fibrillation?
Does contact force-sensing catheter ablation reduce atrial fibrillation or atrial tachycardia recurrence compared to non-contact force ablation in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Contact force-guided pulmonary vein isolation significantly reduces 1-year AF/AT recurrence and procedural times compared to non-contact force ablation in a real-world cohort with predominantly persistent AF.
BACKGROUND: In atrial fibrillation (AF) patients, catheter ablation of pulmonary veins (PVI) is the most effective therapeutic option to maintain sinus rhythm. To improve successful PVI, contact force-sensing (CF) catheters became routinely available. Previous studies did not clearly show superior clinical efficacy in comparison with non-CF catheters. METHODS: We investigated consecutive patients, who underwent index PVI for AF at our hospital between 2012 and 2018. Three hundred and fifty-four patients were ablated without CF. After availability of CF catheters in 2016, 317 patients were ablated using CF. In case of crossover between the groups, follow-up was censored. The primary endpoint was any documented atrial tachycardia (AT) or atrial fibrillation > 30 s after a 3-month blanking period. Secondary endpoints were procedural characteristics and periprocedural complications. RESULTS: There was no significant difference between the groups at baseline except hyperlipidemia. After 365 days of follow-up, 67% of patients in the CF group remained free from AF/AT recurrence compared to 59% in non-CF group (P = 0.038). In multivariable Cox regression analysis, non-CF ablation was an independent risk factor for AF recurrence besides age and persistent AF. Total fluoroscopy time (15 ± 7.6 vs. 28 ± 15.9 min) and total procedure time (114 ± 29.6 vs. 136 ± 38.5 min) were significantly lower for CF-guided PVI (P < 0.001). Complication rates did not differ between groups (P = 0.661). CONCLUSIONS: In our study, the AT/AF recurrence rate and pulmonary vein reconnection rate is lower after CF PVI with a similar complication rate but lower total procedure time and total fluoroscopy time compared to non-CF PVI.
No takes yet. Share an insight, caveat, or question.
Schlögl et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: